Sphingolipids are ubiquitous membrane constituents whose metabolites function as signaling molecules in eukaryotic cells. Sphingosine 1-phosphate, a key sphingolipid second messenger, regulates proliferation, motility, invasiveness, and programmed cell death. These effects of sphingosine 1-phosphate and similar phosphorylated sphingoid bases have been observed in organisms as diverse as yeast and humans. Intracellular levels of sphingosine 1-phosphate are tightly regulated by the actions of sphingosine kinase, which is responsible for its synthesis and sphingosine-1-phosphate phosphatase and sphingosine phosphate lyase, the two enzymes responsible for its catabolism. In this study, we describe the cloning of the Caenorhabditis elegans sphingosine phosphate lyase gene along with its functional expression in Saccharomyces cerevisiae. Promoter analysis indicates tissue-specific and developmental regulation of sphingosine phosphate lyase gene expression. Inhibition of C. elegans sphingosine phosphate lyase expression by RNA interference causes accumulation of phosphorylated and unphosphorylated long-chain bases and leads to poor feeding, delayed growth, reproductive abnormalities, and intestinal damage similar to the effects seen with exposure to Bacillus thuringiensis toxin. Our results show that sphingosine phosphate lyase is an essential gene in C. elegans and suggest that the sphingolipid degradative pathway plays a conserved role in regulating animal development.
Cell proliferation, migration, and apoptosis are critical to embryogenesis. Elucidating the signal transduction pathways that regulate these cellular processes can lead to insights into normal animal development and the pathophysiology of developmental diseases. Sphingosine 1-phosphate (S1P) 1 is an endogenous sphingolipid metabolite that regulates mammalian cell proliferation, apoptosis, and migration (1, 2) . S1P is unique in its ability to function in two signaling capacities, first as an intracellular second messenger and second as a ligand for a subset of G protein-coupled cell surface receptors of the endothelial differentiation gene (Edg) family (3, 4) . Additionally, there is substantial evidence to support the existence of a "sphingolipid rheostat" whereby cell fate decisions are determined by the ratio of intracellular levels of S1P, a known proliferative stimulus, and ceramide, an inducer of apoptosis (5) .
Intracellular levels of S1P are controlled by its synthesis, catabolism, and export to the extracellular space. Sphingosine kinase (SK) catalyzes the phosphorylation of sphingosine, generating S1P (6) . SK activity increases in response to a variety of inducers, including fetal calf serum, platelet-derived growth factor, nerve growth factor, muscarinic acetylcholine agonists, tumor necrosis factor ␣, and cross-linking of the Fc␥RI and Fc⑀RI immunoglobulin receptors (7) (8) (9) (10) (11) (12) (13) . Sphingosine phosphate lyase (SPL) catalyzes the cleavage of S1P at the C 2-3 carbon bond to yield a long-chain aldehyde and ethanolamine phosphate (14) . SPL is a pyridoxal 5Ј-phosphate-dependent member of the carbon-carbon lyase subclass of aldehydelyases. The reaction proceeds optimally at pH 7.4 -7.6, requires chelators due to sensitivity toward heavy metal ions, and is irreversible (15) . SPL activity is ubiquitous in mammalian tissues, with the notable exception of platelets, in which SPL activity is absent. Although modulation of S1P levels is considered the major biological function of this enzyme, the products of the reaction can contribute to synthesis of both fatty acids and phospholipids and have been shown to regulate sterol regulatory element binding protein processing in Drosophila melanogaster, indicating that the effects of this enzyme on lipid metabolism and biology may be broader than previously appreciated (16) . SPL was first identified through a genetic screen for sphingosine resistance in Saccharomyces cerevisiae (17) . Subsequently, functional SPL homologs of Mus musculus and Homo sapiens were cloned and characterized (18, 19) . Furthermore, predicted protein sequences demonstrating significant homology to known SPL proteins in D. melanogaster, Neurospora crassa, Dictyostelium discoideum, Danio rerio, and Arabidopsis thalliensis have been identified, indicating that SPL may be highly conserved. In addition to its degradation by SPL, S1P can be dephosphorylated back to sphingosine. Enzymes capable of catalyzing the dephosphorylation of S1P comprise two groups, the S1P phosphatases, which demonstrate sphingoid base substrate specificity, and a family of lipid phosphatases capable of dephosphorylating various substrates, including lysophosphatidic acid, S1P, and phosphatidic acid (20 -22) .
Knowledge of SPL, SK, and S1P phosphatase gene sequences from a variety of genetically tractable organisms has made possible the use of both forward and reverse genetic approaches to elucidate the role of sphingolipid metabolism in animal development. Recent studies have implicated roles for both S1P and SPL in the developmental processes of different species, including slime mold, zebrafish, and mouse (23) (24) (25) .
In this study, we have identified the gene encoding Caenorhabditis elegans SPL using nucleotide sequence homology and complementation of a yeast SPL mutant. SPL promoter analysis using green fluorescent protein (GFP) reporter constructs indicates tissue specific and developmental regulation of the SPL gene. RNA interference (RNAi) was used to investigate the importance of SPL in regulating metabolism of sphingolipid signaling molecules and the role of SPL in vivo during development and in the adult worm. Our results demonstrate that C. elegans SPL expression is localized to intestinal cells and that interference with SPL expression leads to accumulation of phosphorylated and unphosphorylated long-chain bases. Furthermore, inhibiting SPL expression results in severe intestinal damage, egg laying defects, and semi-lethality. These studies demonstrate the importance of SPL in maintaining tight regulation of bioactive sphingolipid metabolites and indicate that SPL expression has a role in normal gut and reproductive physiology, representing a first step toward understanding the biological importance of the sphingolipid degradative pathway in more complex animals, including humans.
EXPERIMENTAL PROCEDURES
Cloning of C. elegans SPL-Two open reading frames (gi1226312 ϭ B0222.4; gi3801005 ϭ Y66H1B.4) with significant homology to the S. cerevisae SPL gene were identified in the C. elegans genome by BLAST search of the GenBank TM data base (17) . Both these open reading frames were reverse-transcribed and amplified by PCR from total C. elegans RNA using the Access RT-PCR system (Promega) and the DNA primer pairs 5Ј-B0222.4 and 3Ј-B0222.4, and 5Ј-Y66H1B.4 and 3Ј-Y66H1B.4 (Table I) .
After restriction enzyme digestion, the resulting cDNA fragments were cloned into EcoRI (B0222.4) and EcoRI and XhoI (Y66H1B.4) sites of the pYES2 yeast shuttle vector (Invitrogen). The resulting galactoseinducible constructs pYES2-B0222.4 and pYES2-Y66H1B.4 were evaluated for ability to functionally and biochemically complement relevant S. cerevisiae mutant strains. For injected RNAi studies in C. elegans, the B0222.4 and Y66H1B.4 sequences were cloned into pBluescript at the EcoRI and EcoRI/XhoI sites, respectively. Additionally, cDNA of the T07A9.1 gene, which is immediately upstream of Y66H1B.4 on chromosome IV, was amplified by RT-PCR using the DNA primer pair 5Ј-T07A9 and 3Ј-T07A9, and the resulting DNA fragment was cloned into pBluescript (ϩ or Ϫ) at EcoRI and XhoI sites. RNA was produced from the resulting plasmids pBS-B0222.4, pBS-Y66H1B.4, and pBScT07A9.1 as described below.
Generation and Expression of C. elegans Reporter Gene ConstructsFor transcriptional reporter constructs, a promoter region of 512 nucleotides of Y66H1B.4 upstream untranslated sequence corresponding to a position Ϫ3 to Ϫ515 relative to the ATG start codon was generated by PCR from T07A9 cosmid template DNA using Vent DNA Polymerase (New England BioLabs) and the primer pair PstIY66H1B and SmaIY66H1B. Similarly, a promoter region of 3949 nucleotides of T07A9.1 upstream untranslated sequence corresponding to a position Ϫ2 to Ϫ3951 relative to the ATG start codon was generated by PCR from T07A9 cosmid template DNA using the primer pair PstIT07A9 and SmaIT07A9. Following restriction enzyme digestion, these PCR products were cloned into PstI and SmaI sites of the GFP reporter plasmids pPD95.75 and pPD95.67 (gifts of A. Fire and B. Meyer). The resulting constructs, pY66H1B.4.75, pY66H1B.4.67, pT07A9.1.75, and pT07A9.1.67, were used in transgenic experiments.
Creation of Transgenic Animals-Transformation of C. elegans dpy-20(e1362) worms with reporter constructs was performed by microinjection of plasmid DNA into the distal arm of the hermaphrodite gonad as described previously (26, 27) . Reporter construct DNA was co-injected with plasmid pMH86, allowing the recognition of transformants by rescue of the Dpy phenotype (28 Yeast Strains and Growth Conditions-Strain JSK133, a derivative of JK9 -3d containing a dpl1::TRP1 allele, was transformed with pYES2 vector control, pYES2-DPL1, pYES2-B0222.4, and pYES2-Y66H1B.4 using the lithium acetate method (see Table II ) (29) . Transformants were isolated by uracil prototrophy. Cells were grown in uracil media containing 20 g/liter of either glucose or galactose. Sphingosine resistance was analyzed using a dilutional assay, as previously reported (17) . Cells were also plated onto standard YEPD (yeast extract, peptone, dextrose) media as a control. Sphingosine-enriched plates were made with minimal media containing 0.0015% Nonidet P-40 and 50 M Derythro-sphingosine. At this concentration of Nonidet P-40, no effects on cell viability are observed.
SPL Assay-Yeast strains of interest were grown to mid-logarithmic phase (A 600 ϭ 1.0) in uracil media containing galactose as a carbon source. Whole cell extracts were prepared as described previously (17) , adjusted for protein concentration, and evaluated for SPL activity as described using as substrate [ 3 H]dihydrosphingosine 1-phosphate, obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO) (30) . Similarly, worms propagated on Escherichia coli HB101 strain carrying either no vector or a Y66H1B. 4 RNAi feeding construct were harvested, washed in M9 and SPL extraction buffer, homogenized using a Wheaton glass homogenizer, adjusted for protein concentration and evaluated for SPL activity as above. Extracts containing only denatured proteins were prepared by boiling for 5 min.
Worm Propagation and Collection of Staged Animals-Worms were grown under standard conditions in nematode growth medium (31) . To synchronize C. elegans cultures worms were grown in liquid culture, treated with alkaline hypochlorite treatment, resuspended in S basal media, and harvested at various time points to obtain L4 larvae for feeding experiments described below.
RNA Interference by Injection-The B0222.4, Y66H1B.4, and T07A9.1 cDNAs were cloned into pBluescript in the multiple cloning site. RNA complementary to each strand was synthesized using T3 and T7 promoter regions and an in vitro transcription kit (Promega). The two strands were annealed to make double-stranded RNA (dsRNA) and injected into the distal gonads of 12 wild-type (N2 Bristol) young adult C. elegans hermaphrodites as described (27) . Uninjected hermaphrodites and hermaphrodites injected with a control dsRNA were handled in parallel as controls. Eight hours after injection, each hermaphrodite was transferred to a fresh culture plate, and 12-h cohorts of F1 progeny were established. Progeny were examined daily with a dissecting microscope and by Nomarski microscopy (Zeiss Axioscop) until most animals reached adulthood and culture plates became too crowded with F2 progeny (32) .
RNA Interference by Ingestion-Wild-type (N2 Bristol) L4 larvae were plated on E. coli strain HB101 carrying an L440 plasmid containing the Y66H1B.4 insert (kind gift of Julie Ahringer, Cambridge, UK) (33, 34) . This plasmid expresses the corresponding target gene dsRNA when induced with 1 mM isopropyl ␤-D-1-thiogalactopyranoside (IPTG).
TABLE I Primers used in these experiments

Primer name
Primer sequence
L4 worms were fed and allowed to lay eggs, as described previously (35) . Progeny were harvested and evaluated by microscopy and biochemical analysis, as described above.
Labeling of C. elegans Lipids-Worms were treated by RNAi by ingestion as described above, except that worms were plated on IPTG plates at the L1 stage and were harvested at L4 to adult stage. Worms were then collected by scraping and resuspended in 1 ml of S basal media containing 50 M [ 3 H]serine (100 Ci/ml) and incubated for 4 h at 20°C. Following incubation the volume was brought up to 50 ml with M9 buffer, and worms were pelleted by centrifugation at 3000 ϫ g for 10 min at 4°C. Supernatant was discarded, and worms were washed two times with 50 ml of M9 buffer each time. Washed worms were frozen in liquid nitrogen and lyophilized until a flaky powder was obtained. Lyophilized worms were stored at Ϫ80°C until used.
Preparation and Analysis of C. elegans Lipid Extracts-A sample containing 15 mg of lyophilized worms was placed in a glass tube, and 2 ml of ice-cold chloroform/methanol, 1:1 (v/v), was added to the tube. The sample was homogenized by tip sonication (5 ϫ 20 s) while on ice and then centrifuged at 1500 ϫ g for 10 min. Supernatant was recovered, and a second extraction was performed on the pellet. The two supernatants were pooled and dried down in a Speed Vac. Lipid extract was resuspended in 400 l of 1.5 M ammonium hydroxide by tip sonication, and 2 ml of chloroform/methanol, 2:1 (v/v), was added while vortexing. The sample was centrifuged at 1500 ϫ g for 10 min to obtain a clear separation of the two phases. Both phases were recovered and dried down in a Speed Vac. To compare the efficiency of the homogenization and extraction procedure between different samples, the total amount of phosphatidylcholine present in the organic phase was determined following phospholipase B treatment (Waco Chemicals, Neuss, Germany). Lipid equivalent to 250 g of phosphatidylcholine was removed for TLC analysis. Lipid groups were separated by running TLC (Silica Gel HL, 20 ϫ 20 cm, Analtech, Newark, DE) and identified based on known standards. Different solvent systems were applied. Phospholipids were analyzed by applying 10 -20% of the organic phase to a TLC plate followed by a separation using the solvent system chloroform/ methanol/glacial acidic acid/0.9% sodium chloride, 20:10:3.2:1 (v/v, solvent system A). The remainder of the organic phase was subjected to mild alkaline hydrolysis by incubating for 1 h at 37°C in 400 l of methanol containing 0.1 M potassium hydroxide. Following hydrolysis the lipids were dried down, resuspended in chloroform/methanol, 2:1 (v/v), and applied to a TLC plate. Lipids were separated using twodimensional TLC. Plates were developed in the first dimension using the solvent system chloroform/methanol/4.2 M ammonium hydroxide, 9:7:2 (v/v, solvent system B) followed by a separation in the second dimension using solvent system A. Spots corresponding to sphingoid bases and ceramide were identified. Phosphorylated sphingoid bases obtained in the water phase were analyzed using the same two-dimensional TLC procedure. Aliquots were taken out throughout the homogenization and extraction procedures and evaluated for radioactivity by scintillation counting. Spots corresponding to lipids of interest were scraped from the TLC plates and counted for radioactivity.
RESULTS
Identification of C. elegans SPL-Based on a BLASTP search of the GenBank
TM data base against the DPL1 (dihydrosphingosine phosphate lyase) gene sequence of S. cerevisiae, two open reading frames were identified in the C. elegans genome. Open reading frame B0222.4 on cosmid B0222 (representing a portion of chromosome V) had been predicted to encode a glutamate decarboxylase. Predicted coding sequence Y66H1B.4 was identified on yeast artificial chromosome Y66H1B (representing a portion of chromosome IV) and is noted to contain a conserved pyridoxal phosphate-dependent decarboxylase domain. No experimental evidence for the function of either gene was available. These two sequences are 39% identical and 60% similar to one another. Y66H1B.4 is slightly more similar to the SPL protein sequences of S. cerevisiae and Homo sapiens (40% identical to DPL1 and 41% identical to human SPL) compared with B0222.4 (36% identical to DPL1 and 38% identical to human SPL). In each case, the region of similarity spans nearly the entire length of each protein sequence. A predicted pyridoxal 5Ј-phosphate binding lysine (shown in Fig. 1 ) is present in both B0222.4 and Y66H1B.4. However, eliminating the conserved region surrounding this lysine from the comparison did not significantly affect the overall sequence similarity. To determine whether B0222.4 and/or Y66H1B.4 encode a functional SPL, cDNA from each transcript was created by reverse transcription from total C. elegans RNA, amplified by PCR, and cloned into the pYES2 yeast shuttle vector, in which genes are induced in the presence of galactose. Both constructs were then transformed into a haploid S. cerevisiae strain containing a null dpl1 allele, the sole endogenous SPL gene of this organism. This strain is extremely sensitive to the presence of D-erythrosphingosine in the media due to an inability to catabolize this lipid. When active SPL proteins are expressed in this background, sphingosine sensitivity is abrogated. As shown in Fig.  2A , Y66H1B.4 expression in media containing galactose afforded substantial growth of the dpl1 strain on sphingosine, whereas B0222.4 expression supported only marginal growth (Fig. 2B) . To determine whether B0222.4 and/or Y66H1B. 4 were capable of restoring SPL activity to the dpl1 mutant, whole cell extracts of dpl1 strains expressing either Y66H1B. 4 or B0222.4 were prepared and evaluated for activity against a radioactive dihydrosphingosine 1-phosphate substrate. Although Y66H1B.4 expression restored SPL activity to the dpl1 strain, B0222.4 did not (Fig. 3) . These findings indicate that Y66H1B.4 encodes the C. elegans SPL, and we have renamed this gene spl-1.
C. elegans SPL Is Expressed in a Tissue-specific MannerThe organization of the spl-1 gene is shown in Fig. 4 . The coding region of spl-1 resides within a 3.2-kb sequence containing 10 exons and 9 introns on chromosome IV. The intragenic region between spl-1 and its nearest 5Ј neighbor (hypothetical gene T07A9.1) is 521 nucleotides. Due to the small size of this region, Wormbase (available at www.wormbase.org) predicts that spl-1 may be a downstream gene in an operon with T07A9.1. Therefore, to evaluate gene expression from the spl-1 locus, GFP reporter constructs were created from both potential regulatory regions, which are located immediately 5Ј to spl-1 and to the large intragenic region upstream of T07A9.1. Reporter constructs with and without nuclear localization sequences were created to aid in interpretation of the fluorescent signal. Reporter constructs and dpy-20ϩ plasmid pMH86 were simultaneously microinjected into the distal arm of the hermaphrodite gonad of dpy-20(e1362) worms. Transformants were identified by rescue of the Dpy phenotype (28) . Lines in which the F2 and subsequent generations demonstrated the rescue phenotype were considered stable and were analyzed for GFP expression. As shown in Fig. 5 , GFP expression under regulation of the spl-1 immediate upstream region was pronounced and localized almost exclusively in the intestine. All cells of the intestine expressed spl-1. In line PS4246, which transmits the non-Dpy phenotype at 98%, most animals demonstrated a fluorescent signal in the region just posterior to the pharynx with no expression in the rest of the anterior gut. Strong expression was also observed in the posterior gut of most animals. No expression was detected in the gonad, bodywall muscle, pharynx, vulva, or epidermis. Although a low percentage of animals showed some expression in a pair of cells in the head, expression was too weak and variable to identify these cells. This expression pattern was consistent in worms transformed with nuclear localizing reporter constructs and non-nuclear constructs. In contrast, only weak and non-tissuespecific expression from the T07A9.1 promoter constructs was observed (data not shown). C. elegans SPL Expression Is Developmentally RegulatedTo determine whether spl-1 expression is developmentally regulated, GFP fluorescence was analyzed in transgenic animals at all developmental stages. Although we were not able to distinguish non-Dpy nematodes during embryogenesis, early to comma stage embryos in line PS4246, which shows 98% transmission of the transgene in larvae and adults, were devoid of expression and expression in pretzel stage embryos was barely detectable (Table III) . In both transgenic lines analyzed, the majority of L1 larvae and 100% of L2, L3, and L4 larvae and adults showed medium to high expression, with the highest levels of expression noted in older adults (Table III) .
SPL Expression Is Required for Normal Development in C.
elegans-To assess whether the sphingolipid degradative pathway serves a role in C. elegans development, spl-1 expression was inhibited using RNA interference. This method provides a potent and specific block to protein expression by inducing degradation of the targeted endogenous mRNA. Toward that end, full-length SPL dsRNA was created by in vitro transcription and injected into adult hermaphrodite worms, as described under "Experimental Procedures." Animals injected with full-length B0222.4 dsRNA and uninjected animals were employed as negative controls. The resulting F1 progeny were analyzed throughout development until they reached adulthood.
Results representative of 12 separate injections of SPL dsRNA are shown in Fig. 6 . For SPL dsRNA-injected worms, all eggs laid after ϳ12 h post-injection demonstrated abnormalities, although these ranged broadly in severity from worms that did not develop beyond L1 or L2 stages to worms that developed to adulthood and demonstrated defects of adult structures. Compared with control F1s, animals inheriting spl-1 dsRNA developed slowly, moved sluggishly, and were thin, pale, and starved in appearance. The adults were smaller than controls (Fig. 6A ) and did not pump food actively. The treated animals reached adulthood 24 -48 h later than controls. Adult hermaphrodites that inherited spl-1 dsRNA were markedly different from controls especially in the gonad and uterus. Although control animals had abundant nuclei in the distal gonad and a row of developing oocytes in the proximal gonad, affected hermaphrodites had poorly developed distal gonads with fewer nuclei (Fig. 6B) . Control adults had embryos of progressive stages of development in the uterus, whereas the number of developing oocytes in the proximal gonad of affected hermaphrodites was significantly reduced. The embryos in the uterus of affected progeny were also morphologically abnormal. Those near the vulva were at late developmental stages, indi- cating a defect in egg laying. There was not a uniform progression of developmental stages in adjacent embryos suggesting a defect in ovulation or cell division (Fig. 6, C-E) . Embryonic and larval semi-lethality was observed, and some premature death of adults was also noted. None of these effects were found in worms that inherited B0222.4 dsRNA, which were similar in growth, appearance, and reproduction to uninjected worms. Furthermore, no synergistic effects were observed when B0222. 4 and spl-1 dsRNA were injected together.
The Product of the spl-1 Gene Is the Predominant SPL of C. elegans-It
has been shown previously that RNAi can be performed by feeding C. elegans bacteria containing plasmid constructs that express dsRNA of interest (34) . The advantages of this method include its technical simplicity, the large numbers of affected progeny allowing biochemical analysis of treated populations, and ability to manipulate the potency of the effect by altering induction conditions, facilitating the identification of hypomorphic phenotypes. To confirm the developmental phenotypes observed in RNAi by injection, to seek additional phenotypes, and to determine the effect on SPL activity, feeding RNAi was undertaken. Comparison of control worms versus worms treated with spl-1 RNAi by ingestion indicates that SPL enzyme activity is completely inhibited by this procedure (Fig. 7) . Therefore, the enzyme encoded by spl-1 is responsible for most, if not all, SPL activity in the worm.
Inhibition of C. elegans SPL Expression Leads to Intestinal Cell Death and Egg Laying
Defects-Using feeding RNAi, phenotypes similar to those observed in injection RNAi were appreciated, including pallor, shrunken gonads, bloated appearance, and unlaid eggs (Fig. 8) . Rare adult hermaphrodite worms were identified with hatched larvae within them (the "bag of worms" phenotype). Pallor was a consistent finding, present in all progeny of treated animals. Furthermore, the intestines of many worms appeared strikingly abnormal, shrunken and vacuolated. The onset of these defects was late. Worms appeared normal throughout the larval stages, whereas pallor became evident as worms reached early adulthood, and more pronounced phenotypes were appreciated only in adults more than 24 h old. These phenotypes persisted in adult worms transferred to non-transformed bacterial plates, indicating that the defects caused by SPL inhibition are irreversible. Whereas egg laying was unaffected in worms fed RNAi as adults, it was modestly diminished in worms subjected to RNAi throughout development (data not shown).
The Observed Developmental Defects Are Specific to spl-1-Although the reporter studies described above indicate that spl-1 is transcribed independently of T07A9.1 and is unlikely to be in an operon regulated by the T07A9.1 promoter, it was important to verify that the phenotypes observed in spl-1 RNAi-treated worms were caused by inhibition of spl-1 expression rather than a polar effect leading to a block in expression of the hypothetical T07A9.1 protein product. To maximize the potency of the block in expression, injected RNAi was employed to inhibit expression of T07A9.1. Importantly, inhibition of T07A9.1 expression resulted in no demonstrable effects on egg laying, gonadal development, or growth of the injected worms (data not shown). Therefore, it appears that specific inhibition of spl-1 expression produces the aforementioned abnormalities in the growth, developmental progression, and reproduction of C. elegans.
Inhibition of C. elegans SPL Expression Leads to Accumulation of Phosphorylated and Unphosphorylated Long-chain
Bases-To gain insight into potential mechanisms responsible for the developmental defects observed in SPL-deficient worms, the effect of spl-1 RNAi on serine incorporation into worm sphingolipids and phospholipids was examined, as described under "Experimental Procedures." As shown in Table IV , spl-1 RNAi treatment was associated with a 1.7-fold increase in the amount of serine incorporated into phosphorylated long-chain bases and a 2.7-fold increase in unphosphorylated long-chain bases in comparison to control worms. In contrast, serine incorporation into ceramide, phosphatidylserine, phosphatidylethanolamine, and phosphatidylcholine was not appreciably altered in the RNAi worms. Thus, specific accumulation of phosphorylated and unphosphorylated long-chain bases results (dpl1 ϩ vector) or with pYES2-Y66H1B.4 (dpl1ϩ Y66H1B.4) were adjusted for A 600 ϭ 5 and serially diluted as indicated. Cells were template-inoculated onto YEPD plates or plates containing sphingosine and galactose as a carbon source, as described under "Experimental Procedures." B, same as above, except that strains include wild type, JSK133 plus vector, JSK133 plus pYES2-B0222.4 (dpl1 ϩ B0222. 4) , and JSK133 plus pYES2-DPL1 (dpl1 ϩ DPL1). This is representative of three separate experiments.
from RNAi treatment and may contribute to the reproductive and anatomical defects observed in spl-1-deficient worms.
DISCUSSION
In this study, we have identified the C. elegans SPL gene as "spl-1" using nucleotide sequence homology searches and functional complementation in yeast. This gene appears to encode the sole or predominant SPL in C. elegans, because inhibition of its expression is associated with undetectable levels of SPL activity in vivo.
C. elegans spl-1 expression is regulated in a tissue-specific manner, with robust expression detected in intestinal cells and faint expression in the head. Our data are in agreement with a more extensive C. elegans developmental analysis presented by the Nematode Expression Pattern Data base (36) . This highly restricted tissue specificity is unlike that found in Homo sapiens and Mus musculus, where SPL is expressed in most tissues. Little is known about the physiology of C. elegans intestinal cells, although they have been shown to store nutrients and secrete digestive enzymes into the gut lumen and are likely to carry out detoxification, storage, and metabolic functions (37) . Although in its natural environment C. elegans might ingest plant particles containing sphingolipids, laboratory strains are raised solely on E. coli, which does not synthesize or contain sphingolipids. Intermediates that accumulate in the absence of SPL activity may, thus, be derived from endogenous pathways or potentially from trace sphingolipids present in the culture media. It is possible that the localization of spl-1 points toward a critical function in gut development and/or maintenance of intestinal integrity. Interestingly, we have observed a similar intestine-specific expression pattern in the SPL of D. melanogaster, indicating that this may be a widespread phenomenon in invertebrate organisms (38) . Furthermore, the finding of spl-1 expression in the head indicates a potential role in neurodevelopment, which is consistent with evidence suggesting a role for lysophospholipid signaling in nervous system development and function in mammals (39) .
The onset of spl-1 expression occurs at the time of egg hatching, and expression remains high throughout the life of the organism. The results of our GFP reporter assays indicate that the small intragenic region immediately upstream of Y66H1B.4 is the true spl-1 promoter. It appears that this ϳ500-bp region is sufficient to provide both spatial and temporal regulation of spl-1 gene expression. Systematic study of this promoter using reporter gene constructs, mutational analysis, and deletional analysis should allow identification of the specific sequences involved in the regulation of spl-1 expression. Analysis of sphingolipid metabolites throughout development, in combination with the use of transgenic approaches resulting in ectopic and/or constitutive spl-1 expression, should elucidate the functional significance of this pattern of gene expression.
Importantly, C. elegans spl-1 expression is critical for the maintenance of intestinal integrity and normal reproduction. Without spl-1 expression, animals become bloated, pale, congested with eggs and hatched larvae, and demonstrate shrunken gut and gonadal structures. The finding of a phenotype involving intestinal cell integrity in SPL-inhibited animals is consistent with its observed expression pattern, whereas effects on the gonad are less directly explained. It could be postulated that the gonadal and egg laying defects observed in the spl-1 RNAi-treated worms is due to a nonspecific effect of starvation. However, this is not likely, because this type of reproductive defect has not been described in other mutants in which starvation is a prominent feature (40) . Furthermore, diminished egg laying was observed only in worms treated with spl-1 RNAi throughout development, suggesting that this defect has a developmental basis. Interestingly, the intestine appears to play a critical role in the nurture of germ cells by producing yolk proteins that are imported into the developing oocytes and serving as nurse cells for the primordial germ cells (37) . Therefore, potential toxicity to intestinal cells induced by S1P accumulation or other metabolic disturbances associated with spl-1 inhibition may affect egg maturation by blocking this supportive role of intestinal cells in reproduction. S1P may have direct effects on reproduction, provided it can move from intestinal cells to other tissues through normal diffusion, secretion, or facilitated transport. This concept is supported by the observation that S1P concentration gradients regulate mammalian endothelial and smooth muscle cell migration through receptor signaling mechanisms (41, 42) . Alternatively, once intestinal cell membranes are disrupted and the integrity of the intestinal tract has been violated, S1P and/or other metabolites and digestive enzymes may escape, causing pleiotropic effects on nearby organs.
Interestingly, the vacuolization, pallor, shrinkage, and ultimate destruction of the intestines, as well as the gonadal defects observed in worms treated with spl-1 RNAi are remarkably similar to that observed in worms treated with Cry proteins of the Bacillus thuringiensis (Bt) bacterium. These potent natural insecticides have been utilized to create transgenic food plants resistant to a wide variety of insect pests (43, 44) . Although their precise mode of action is not known, these toxins induce cell damage by intercalating into the cell membranes of insect midgut epithelial cells, causing pore formation (45, 46) . C. elegans also develops intestinal damage in response to some Cry proteins (47, 48) . How might Bt toxin and spl-1 inhibition induce the same effect on nematode intestinal cells? S1P accumulation may result in a direct or indirect disruption of the membrane integrity of the intestinal cell. Lysophospho- FIG. 7 . SPL activity after RNAi by ingestion. Worms were treated with RNAi constructs as described in Fig. 8 . Control animals were grown on plates containing IPTG and OP50 (no RNAi construct). At 48 h, worms were harvested, washed to remove bacteria, and homogenized using a Wheaton glass homogenizer followed by vortexing in the presence of glass beads. Extracts were normalized for protein content and assayed for SPL activity as described under "Experimental Procedures." For RNAi-treated versus untreated worms, p Ͻ 0.001. Residual SPL activity in RNAi-treated worms is apparent when compared with a denatured extract from wild type worms (Denatured Wild Type). lipids are known to exert various membrane modulating influences, including detergent effects that result in destabilization and disruption of membranes and chaperone-like effects, which facilitate protein folding (49 -51) . Either direct membrane disruption or interference with ion channels or other proteins required to maintain membrane stability and integrity could ultimately result in cell lysis. Other plausible mechanisms include inhibition of SPL-1 protein by Bt toxin, binding of Bt toxin to SPL-1 in membranes, or influences on downstream signaling events common to both the Bt toxin pathway and S1P pathways.
Finally, spl-1 RNAi treatment led to significant accumulation of both phosphorylated and unphosphorylated long-chain bases, as would be expected from a block in SPL activity (Fig.  9) . (In contrast, inhibiting expression of a putative C. elegans SK led to a substantial increase in long-chain bases but no increase in phosphorylated long-chain bases.) 2 The observed lipid changes are specific, in that phospholipid and ceramide levels are not significantly perturbed by loss of spl-1 expression. Increases in long-chain bases of this magnitude are consistent with levels observed in mutant models lacking spl-1 expression in other organisms, as well as in mammalian cells in which the SPL gene is disrupted and in mammalian cells overexpressing recombinant SK (38, (52) (53) (54) . In each of the above cases, this degree of phosphorylated long-chain base accumulation was sufficient to induce signals and result in downstream biological effects. Thus, the perturbation of phosphorylated long-chain bases observed in our experiments could potentially exert significant physiological effects in the developing and adult worm.
In summary, our results demonstrate that spl-1 is an essential gene in C. elegans and that inhibiting spl-1 expression results in accumulation of bioactive sphingolipid metabolites and associated severe developmental and reproductive phenotypes and indicate that the sphingolipid degradative pathway plays a conserved role in the regulation of animal development. FIG. 9 . Sphingolipid accumulation in spl-1 RNAi-treated worms. 1, sphingosine kinase; 2, sphingosine phosphate phosphatase; 3, sphingosine phosphate lyase (spl-1); 4, ceramide synthase; 5, sphingosine desaturase; 6, ceramidase. Sphingolipid intermediates shown in boxes accumulate in spl-1 RNAi-treated worms. Asterisk, note that sphingosine and dihydrosphingosine cannot be distinguished in the TLC assay system used in these experiments. Likewise, the phosphorylated forms cannot be distinguished. a LCBP ϭ long chain phosphorylated base; LCB ϭ long chain base; PS ϭ phosphatidylserine; PE ϭ phosphatidylethanolamine; WT ϭ wild type; ⌬SPL ϭ spl-1 RNAi.
